News

Sharif Sayed Joins Le-Vel as Brand & E-Commerce Performance Director, Bringing Expertise to Elevate Growth and Innovation

Sharif Sayed joins global wellness company & brings diverse experience to role FRISCO, Texas, Jan. 31, 2025 /PRNewswire/ -- Le-Vel is…

11 months ago

Data Vault Holdings Inc. Rebrands as EOS Technology Holdings Inc., Ushering in a New Dawn of Innovation

EOS Aerospace and EOS Earth Divisions to Continue Innovation Legacy Following WiSA Technologies' Strategic Asset Acquisition NEW YORK, Jan. 31,…

11 months ago

VANTAGE FOUNDATION PARTNERS WITH SOS CHILDREN’S VILLAGES PHILIPPINES TO EMPOWER VULNERABLE CHILDREN AND FAMILIES

MANILA, Philippines, Jan. 31, 2025 /PRNewswire/ -- Vantage Foundation proudly announces its partnership with SOS Children's Villages Philippines, a NGO committed…

11 months ago

Augnito Secures Major Enterprise Partnership with Almoosa Health

Groundbreaking collaboration establishes a new benchmark for AI-driven clinical workflows in the Kingdom of Saudi Arabia RIYADH, Saudi Arabia, Jan. 31, 2025 /PRNewswire/ -- Augnito, a global leader in medical voice…

11 months ago

Hisense Secures No. 2 Spot in Global TV Shipments Share for Third Consecutive Year

DUBAI, UAE, Jan. 31, 2025 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, has reinforced…

11 months ago

Medexus Pharmaceuticals Announces Closing of $30 Million Overnight Marketed Public Offering of Common Shares

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 31, 2025) - Medexus Pharmaceuticals Inc. (TSX: MDP) ("Medexus" or the "Company"),…

11 months ago

Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade

Multilingual upgrade will make INBS’ Drug Screening System accessible to over 4 billion users worldwide, including users across the Americas,…

11 months ago

Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

CHAPEL HILL, N.C., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a…

11 months ago

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results

 ●Q4 and FY Test volume increase 21% and 17% year-over-year ●Q4 and FY Volume, Revenue, and Profitability at all-time record levels…

11 months ago